HMH Maestro

Clinical Alerts

FDA Approves Generic Narcan Nasal Spray

All LocationsAll Specialties

What You Need To Know

In an effort to reduce the number of opioid-related overdose deaths, the FDA has approved the first generic naloxone nasal spray for use in a community setting by individuals without medical training.

The FDA is also taking these life-saving measures:

Reminder: Opioid Training Deadline is June 30

The State Board of Medical Examiners’ deadline for mandatory opioid training is June 30, 2019. Hackensack’s May 16 CME event will help you meet this requirement.

For More Information